advertisement
Abstract #20321 Published in IGR 10-1
The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy
Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WCCurrent Eye Research 2007; 32: 1037-1043
PURPOSE: To evaluate the incidence and characteristics of periocular pigmentation with latanoprost versus bimatoprost. METHODS: A retrospective, active-controlled comparison of consecutive patients treated with latanoprost or bimatoprost for 12 months evaluating patients to determine the incidence, characteristics, and reversibility of periocular pigmentation. RESULTS: Periocular pigmentation was found in 1% patients treated with latanoprost and 6% patients treated with bimatoprost within 12 months of beginning treatment (p = 0.004). CONCLUSIONS: This study suggests that periocular pigmentation may develop after treatment with latanoprost or bimatoprost.
Dr. E.D. Sharpe, Glaucoma Consultants and Center For Eye Research, Mount Pleasant, South Carolina, USA
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)